Zymeworks Inc. (ZYME) Discusses Portfolio Strategy, Roche Partnership and Pipeline Updates Transcript

What happened: Zymeworks Inc. (ZYME) held a conference call to discuss portfolio updates, its R&D strategy, the Roche partnership announced the prior Friday, and pipeline updates. Why it matters: The call covered the design of ZW209 and ESMO data on ZW191 and zanidatamab presented by partners Jazz and BeOne. The Roche agreement remains subject to HSR clearance. Key numbers: Call held October 27, 2026 at 8:30 AM EDT.

Zymeworks Inc. (ZYME) held a conference call to discuss portfolio updates, its R&D strategy, the Roche partnership announced the prior Friday, and pipeline updates.

The call covered the design of ZW209 and ESMO data on ZW191 and zanidatamab presented by partners Jazz and BeOne. The Roche agreement remains subject to HSR clearance. Key numbers: Call held October 27, 2026 at 8:30 AM EDT.